Maintaining Results After Teeth Whitening Procedures

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

A perfect, bright smile radiates self-confidence and a lasting impression. For residents in Atlanta, where cosmetic dental services are widely accessible, maintaining that brightness after a procedure is just as important as the treatment itself. A lot of people go for teeth whitening procedures to get whiter teeth that look and feel healthy. But these […]

The post Maintaining Results After Teeth Whitening Procedures appeared first on Medical News Bulletin.

Understanding UTI at Home Tests: A Convenient Way to Monitor Urinary Health

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

Common health problems that may impact both men and women are infections of the urinary tract, or UTIs for short. They often happen when germs get into the urinary system, harming it and causing an infection. Symptoms involve torching when peeing, murky urine, lower stomach ache, and frequent impulses to use the toilet. Many people […]

The post Understanding UTI at Home Tests: A Convenient Way to Monitor Urinary Health appeared first on Medical News Bulletin.

How a Facial Treatment Helps You Take Care of Your Skin

Medical News Bulletin - Daily Medical News, Health News, Clinical Trials And Clinical Research, Medical Technology, Fitness And Nutrition News–In One Place

It’s easy: taking care of your skin will make you appear nice. This can constantly make your skin appear tired and lifeless. A facial treatment can help with that. if you’re looking for a spa near you that will help you unwind while also improving your skin. From strong sunlight and UV rays to air […]

The post How a Facial Treatment Helps You Take Care of Your Skin appeared first on Medical News Bulletin.

Cutting-edge technologies are poised to transform orthopedics

Orthopedic surgery has always evolved alongside technology, from advances in biomaterials to minimally invasive techniques.
Today, however, the pace of innovation is accelerating. AI, robotic assistance, virtual reality (VR), augmented reality (AR) and smart digital tools are no longer experimental concepts. Increasingly, these technologies are being integrated into daily orthopedic practice, with the promise of improving precision, efficiency and patient outcomes. While not every innovation will prove transformative, several emerging technologies are already changing how surgeons evaluate

Axpaxli meets primary endpoint vs. aflibercept in wet AMD

In a phase 3 trial, Axpaxli, a tyrosine kinase inhibitor, achieved its superiority primary endpoint vs. aflibercept for the treatment of wet age-related macular degeneration, according to a press release from Ocular Therapeutix.
“Despite advances in [neovascular age-related macular degeneration] treatment, there remains unpredictability around patient response to treatment, resulting in unsustainable burden and lack of adherence,” Pravin U. Dugel, MD, executive chairman, president and CEO of Ocular Therapeutix, told Healio. “In addition, fluid fluctuations and increased fibrosis lead to poor

Financial hardship has significant impact on cancer-related pain

Patients who have financial hardships have a significantly higher likelihood of experiencing moderate or severe cancer-related pain than those who do not.
A retrospective analysis also showed patients with financial hardship have higher rates of opioid use, despite their fiscal condition.
“Financial hardship is clinically impactful,” Courtney P. Williams, DrPH, assistant professor in the division of General Internal Medicine and Population Science at The University of Alabama at Birmingham (UAB) Heersink School of Medicine and associate scientist at O’Neal Comprehensive Cancer Center, told

FDA reverses decision, will review Moderna’s mRNA flu vaccine

Reversing its initial decision, the FDA has agreed to review Moderna’s messenger RNA-based influenza vaccine for approval, the company announced Wednesday.
The reversal came about 2 weeks after the FDA sent Moderna a letter explaining that it would not review the company’s application for its mRNA influenza vaccine, mRNA-1010, because the agency felt the application did not contain an “adequate and well-controlled” trial.
Specifically, the agency said it had an issue with the comparator vaccine used in the trial — the FDA-approved, standard dose seasonal influenza vaccine. According

Ophthalmologists: Encourage use of protective eye wear in sports

Sports-related injuries are extremely common in every eye doctor’s practice.
These injuries are more common in younger patients between the ages of 10 and 19 years, in male patients, during competition vs. practice and especially when protective eye wear is not used. For example, 97% of injuries in basketball, baseball/softball and fishing occur in individuals not wearing protective eye wear. The common causes include trauma from balls, hands/fingers, heads, knees, elbows, rackets/sticks and fishing lures/rods.
Common injuries, in elevating severity, include periocular contusion,

Nephrology fellows concerned about addressing health disparities

Nephrology fellows expressed concern about health care disparities in practice, but only 61% said they feel confident to address them, according to survey data published in Clinical Journal of the American Society of Nephrology.
Previous surveys have found that physician-trainees recognize the importance of equity in kidney care, both for their own professional values and for optimizing patient outcomes, according to Areeba Jawed, MD, clinical associate professor in the division of nephrology at University of Michigan Medical School, and colleagues. However, perspectives from nephrology

Interim data show RSV vaccination safe during pregnancy

An interim analysis of safety data showed no increased risk associated with Pfizer’s respiratory syncytial virus vaccine when given to pregnant women, researchers reported recently in JAMA.
The FDA approved the vaccine, Abrysvo, in August 2023 based on data that showed it prevented RSV in infants during their first 6 months after birth. It is administered in a single dose between weeks 32 and 36 of pregnancy.
“As part of our commitment to patient safety, all Pfizer products are monitored continuously for safety before and after approval,” Sarah MacDonald, ScD, ScM, epidemiologist and director